Poster SESSIONS
62
Poster, 24 June 2014
P-24-002
Effects of high-fat diet and binge-like food
intake on cognitive performance in the
5-choice serial reaction time task
Jacob Sussman, Vancouver, Canada
W. Adams, C. Winstanley
P-25
POSTER SESSION
17:15–18:45
Hall B
Schizophrenia B
P-25-001
Metabolic risk and status with continuous
antipsychotic treatment in chronic schizo-
phrenia patients between 2-year period
Kentaro Kawabe, Toon, Ehime, Japan
S. Ochi, Y. Yoshino, T. Ishimaru, Y. Mori, H. Onu-
ma, H. Osawa, S.-I. Ueno
P-25-002
Effects of clozapine on dopamine dynamics
in the amygdala of stress-sensitive animals
Masahiko Kawano, Tokyo, Japan
H. Muraoka, T. Kawano, M. Yamada, J. Miyagi,
H. Oshibuchi, K. Inada, J. Ishigooka
P-25-003
Seizures, EEG abnormalities, and clinical
response during clozapine therapy in Japa-
nese patients with schizophrenia
Yuka Kikuchi, Akita, Japan
K. Ataka, K. Yagisawa, Y. Omori, T. Kanbayashi,
T. Shimizu
P-25-004
Association study of methamphetamine- and
phencyclidine-responsive gene, WD repeat
domain 3, in schizophrenia
Momoko Kobayashi, Tokyo, Japan
N. Yamamoto, D. Jitoku, Y. Iwayama, T. Yoshi-
kawa, T. Nishikawa
P-25-005
Transcriptomic evidence for immaturity of
the prefrontal cortex in patients with schizo-
phrenia
Tsuyoshi Miyakawa, Toyoake, Japan
H. Hagihara, K. Ohira, K. Takao
P-25-006
Effects of n-acetylcysteine on clinical symp-
toms in subjects with at-risk mental state:
A case series
Nobumi Miyake, Kawasaki, Japan
S. Miyamoto, Y. Yamashita, Y. Ninomiya, J. Arai,
S. Tsukahara, Y. Ito, M. Tadokoro, T. Iwakura,
H. Nakamura, N. Yamaguchi
P-25-007
Clinical and biological correlates of re-
silience in patients with schizophrenia:
A cross-sectional study
Yuya Mizuno, Tokyo, Japan
T. Suzuki, A. Hofer, W. W. Fleischhacker, T. Uchi
da, K. Yoshida, H. Sakurai, K. Watanabe, M. Mi
mura, H. Uchida
P-25-008
Effect of aripiprazole on cognitive function
and functional capacity in antipsychotic-na-
ïve first-episode schizophrenia: First report
Yuriko Ninomiya, Kawasaki City, Kanagawa,
Japan
S. Miyamoto, T. Tenjin, N. Miyake, S. Ogino,
H. Harada, Y. Yamashita, Y. Kaneda, T. Sumi-
yoshi, N. Yamaguchi
P-25-009
Blonanserin ameliorates phencyclidine-
induced impairment of visual recognition
memory (2): Involvement of dopamine-D
1
receptor-PKA signaling
Yukihiro Noda, Nagoya, Japan
H. Hida, A. Mouri, K. Mori, K. Yamada, N. Oza-
ki, T. Nabeshima
P-25-010
Translating study results into real-world psy-
chiatric practice: An experience in a male,
locked, non-acute unit serving for persis-
tently ill patients over one year
Takefumi Suzuki, Tokyo, Japan
H. Uchida, K. Tsunoda, M. Mimura
P-25-011
Effect of antipsychotics on telomere length
in the hippocampus
Kazuya Toriumi, Tokyo, Japan
M. Miyashita, T. Ichikawa, A. Kobori, I. Nohara,
M. Arai, N. Obata, M. Itokawa
P-25-012
Is sustained dopamine D2 receptor block-
ade above 65% necessary for maintenance
treatment of schizophrenia? A single-blind,
randomized, controlled study
Takashi Tsuboi, Tokyo, Japan
T. Suzuki, R. R. Bies, G. Remington, B. G. Pol-
lock, J. Hirano, M. Mimura, H. Uchida
P-25-013
Postnatal development of patterns of basal
and schizophrenomimetic phencyclidine-
induced gene expression in the rat neocortex
Masakazu Umino, Bunkyo-Ku, Tokyo, Japan
A. Umino, N. Yamamoto, T. Nishikawa
